Anesthesia management for percutaneous mitral valve repair in a patient with mitochondrial cardiomyopathy and low cardiac function: a case report
Background Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Alt...
Saved in:
| Published in: | JA clinical reports Vol. 10; no. 1; pp. 49 - 5 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
08-08-2024
Springer Nature B.V SpringerOpen |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly.
Case presentation
A 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35–1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery.
Conclusion
Anesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. |
|---|---|
| AbstractList | Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly.BACKGROUNDMitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly.A 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35-1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery.CASE PRESENTATIONA 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35-1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery.Anesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy.CONCLUSIONAnesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly. A 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35-1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery. Anesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. Abstract Background Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly. Case presentation A 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35–1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery. Conclusion Anesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. BackgroundMitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly.Case presentationA 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35–1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery.ConclusionAnesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. Background Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is challenging due to risks of circulatory depression associated with anesthesia and mitochondrial dysfunction induced by anesthetics. Although there are reports of anesthetic management for patients with mitochondrial diseases, there are few reports specifically addressing cardiac anesthesia for patients with mitochondrial cardiomyopathy. We present a case where percutaneous mitral valve repair with MitraClip™ was successfully performed under remimazolam anesthesia in a patient with mitochondrial cardiomyopathy who developed functional mitral valve regurgitation due to low cardiac function and cardiomegaly. Case presentation A 57-year-old woman was diagnosed with chronic cardiac failure, with a 10-year history of dilated cardiomyopathy. She was diagnosed with mitochondrial cardiomyopathy 8 years ago. Over the past 2 years, her cardiac failure worsened, and mitral valve regurgitation gradually developed. Surgical intervention was considered but deemed too risky due to her low cardiac function, with an ejection fraction of 26%. Therefore, percutaneous MitraClip™ implantation was selected. After securing radial artery and central venous catheterization under sedation with dexmedetomidine, anesthesia was induced with a low dose of remimazolam 4 mg/kg/h. Anesthesia was maintained with remimazolam 0.35–1.0 mg/kg/h and remifentanil 0.1 μg/kg/min. Noradrenaline and dobutamine were administered intraoperatively, and the procedure was completed successfully without circulatory collapse. The patient recovered smoothly from anesthesia and experienced no complications. She was discharged on the eighth day after surgery. Conclusion Anesthesia management with remimazolam appears to be a safe and effective for MitraClip™ implantation in patients with mitochondrial cardiomyopathy. |
| ArticleNumber | 49 |
| Author | Oyoshi, Takafumi Hirata, Naoyuki Korematsu, Shinnosuke Tashima, Koichiro Hayashi, Masakiyo Uemura, Jo |
| Author_xml | – sequence: 1 givenname: Koichiro surname: Tashima fullname: Tashima, Koichiro organization: Department of Anesthesiology, Kumamoto University Hospital – sequence: 2 givenname: Masakiyo surname: Hayashi fullname: Hayashi, Masakiyo organization: Department of Anesthesiology, Kumamoto University Hospital – sequence: 3 givenname: Takafumi surname: Oyoshi fullname: Oyoshi, Takafumi organization: Department of Anesthesiology, Kumamoto University Hospital – sequence: 4 givenname: Jo surname: Uemura fullname: Uemura, Jo organization: Department of Anesthesiology, Kumamoto University Hospital – sequence: 5 givenname: Shinnosuke surname: Korematsu fullname: Korematsu, Shinnosuke organization: Department of Anesthesiology, Kumamoto University Hospital – sequence: 6 givenname: Naoyuki orcidid: 0000-0002-3776-8115 surname: Hirata fullname: Hirata, Naoyuki email: naohirata@mac.com organization: Department of Anesthesiology, Kumamoto University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39115707$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1vFCEYx4mpsbX2C3gwJF68jMIwCzPemsaXJk286Jk8vO2ymYEVmDbbb9FvLLtTq_HgCfLwe37A83-JTkIMFqHXlLyntOcfckeGnjak7RpCBOua-2forGWcNUOtnfy1P0UXOW8JIZS3nPf9C3TKBkpXgogz9HAZbC4bmz3gCQKs7WRDwS4mvLNJzwWCjXPGky8JRnwL463Fye7AJ-wDBryD4g8dd75sDlTUmxhM8hXWkIyP0z5WZrPHEAwe491SBo3dHHTxMXysFg35qI2pvELPHYzZXjyu5-jH50_fr742N9--XF9d3jS6Y6w0TFA6OFVnQJXqKO1aDYS2LRN6UFT1w6AtaQcgDtxKaMMEo84Jw8FZaw1n5-h68ZoIW7lLfoK0lxG8PBZiWktIxevRSqAatNZGqR46x4Ryqu85MMJaZjrDquvd4tql-HOuA5WTz9qO4zI9ychAOBMDO6Bv_0G3cU6h_vRIiRUnvK9Uu1A6xZyTdU8PpEQe8pdL_rLmK4_5y_va9OZRPavJmqeW32lXgC1ArkdhbdOfu_-j_QVYjsCH |
| Cites_doi | 10.1097/ALN.0b013e31822a2316 10.1111/j.1600-0773.1996.tb00182.x 10.1007/s10863-016-9673-9 10.1186/s40981-021-00491-3 10.1196/annals.1338.019 10.1186/s40981-018-0207-9 10.1016/j.bja.2018.12.025 10.1111/1440-1681.13840 10.1186/s40981-022-00528-1 10.1016/S0140-6736(00)04064-2 10.1111/pan.12158 10.1007/s00540-023-03242-z 10.1111/j.1399-6576.2011.02628.x 10.1093/eurheartj/ehad177 10.1113/jphysiol.2002.025015 10.1007/s00540-022-03037-8 10.1097/00000542-200205000-00036 10.1016/j.cell.2020.02.051 10.1007/s00540-020-02776-w 10.1093/ehjcr/ytad440 10.1097/00000542-200510000-00046 10.1111/j.1460-9592.2006.02043.x 10.1007/s00540-020-02788-6 10.1007/s12630-023-02514-2 10.1212/WNL.0b013e3182a1aa78 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.1186/s40981-024-00734-z |
| DatabaseName | SpringerOpen PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2363-9024 |
| EndPage | 5 |
| ExternalDocumentID | oai_doaj_org_article_a1cacccdbb8a4f37bfb886a30323d4d3 10_1186_s40981_024_00734_z 39115707 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 7X7 8FI 8FJ AAFWJ AAJSJ AAKKN AAYZJ ABEEZ ABUWG ACACY ACGFS ACULB ADBBV ADINQ AFGXO AFKRA AFPKN AHBXF AHBYD AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP ASPBG BCNDV BENPR BFQNJ BPHCQ BVXVI C24 C6C CCPQU EBLON EBS FYUFA GROUPED_DOAJ HMCUK IAO M~E OK1 PIMPY PQQKQ PROAC RPM RSV SOJ UKHRP ITC NPM PGMZT AAYXX CITATION 3V. 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c433t-37119fb9811bb41142ca012237c9b1b899ce029a0faf57cd3731ff7d6afeeed63 |
| IEDL.DBID | C24 |
| ISSN | 2363-9024 |
| IngestDate | Tue Oct 22 15:12:59 EDT 2024 Sat Oct 26 04:24:20 EDT 2024 Thu Oct 10 22:21:44 EDT 2024 Fri Nov 22 02:32:17 EST 2024 Sat Nov 02 12:24:48 EDT 2024 Fri Aug 09 01:10:27 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Mitochondrial cardiomyopathy Remimazolam MitraClip Percutaneous mitral valve repair |
| Language | English |
| License | 2024. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c433t-37119fb9811bb41142ca012237c9b1b899ce029a0faf57cd3731ff7d6afeeed63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-3776-8115 |
| OpenAccessLink | http://link.springer.com/10.1186/s40981-024-00734-z |
| PMID | 39115707 |
| PQID | 3090756068 |
| PQPubID | 4402918 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a1cacccdbb8a4f37bfb886a30323d4d3 proquest_miscellaneous_3090637933 proquest_journals_3090756068 crossref_primary_10_1186_s40981_024_00734_z pubmed_primary_39115707 springer_journals_10_1186_s40981_024_00734_z |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-08 |
| PublicationDateYYYYMMDD | 2024-08-08 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-08 day: 08 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | JA clinical reports |
| PublicationTitleAbbrev | JA Clin Rep |
| PublicationTitleAlternate | JA Clin Rep |
| PublicationYear | 2024 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V SpringerOpen |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V – name: SpringerOpen |
| References | Kitaura, Kosumi, Iwamoto, Nakao (CR6) 2022; 8 Nam, Yim, Choi, Park, Joung, Song (CR21) 2023; 70 Huruma, Saji, Nanasat, Isobe (CR7) 2023; 7 Satoh, Nishihara, Sawashita, Ohno, Hirata, Yamakage (CR24) 2021; 2021 Colleoni, Costa, Gori, Santagostino (CR17) 1996; 78 Doi, Hirata, Suzuki, Morisaki, Morimatsu, Sakamoto (CR19) 2020; 34 Wolf, Weir, Stone, Shield (CR4) 2001; 357 Fujii, Tanaka-Mizuno, Fujino, Fujii, Furuno, Sugimoto (CR25) 2018; 4 Morgan, Hoppel, Sedensky (CR3) 2002; 96 Wu, Tai, Chen, Lin, Ueng, Chen (CR12) 2005; 1042 Doi, Morita, Takeda, Sakamoto, Yamakage, Suzuki (CR18) 2020; 34 Russell, Gorman, Lightowlers, Turnbull (CR1) 2020; 181 Vanlander, Jorens, Smet, De Paepe, Verbrugghe, Van den Eynden (CR16) 2012; 56 Hirata (CR23) 2023; 37 Yoshikawa, Oura, Kanda, Chaki, Hirata, Edanaga (CR20) 2024; 51 Drissen, Willems, Dercksen, Giele, van der Staak, Smeitink (CR8) 2007; 17 Bergamini, Moruzzi, Volta, Faccioli, Gerdes, Mondardini, Fato (CR11) 2016; 48 Hemphill, McMenamin, Bellamy, Hopkins (CR13) 2019; 122 Uezono, Hotta, Takakuwa, Ozaki (CR14) 2005; 103 Hirata, Shim, Pravdic, Lohr, Pratt, Weihrauch (CR10) 2011; 115 Sajima, Onimaru, Sawamura (CR26) 2021; 7 Braunwald (CR2) 2023; 44 Niezgoda, Morgan (CR5) 2013; 23 Savard, Dupre, Turgeon, Desbiens, Langevin, Brunet (CR15) 2013; 81 Hasegawa, Hirata, Yoshikawa, Yamakage (CR22) 2022; 36 Hanley, Ray, Brandt, Daut (CR9) 2002; 544 E Fujii (734_CR25) 2018; 4 T Sajima (734_CR26) 2021; 7 M Doi (734_CR19) 2020; 34 T Huruma (734_CR7) 2023; 7 C Bergamini (734_CR11) 2016; 48 M Savard (734_CR15) 2013; 81 S Uezono (734_CR14) 2005; 103 E Braunwald (734_CR2) 2023; 44 N Hirata (734_CR23) 2023; 37 A Wolf (734_CR4) 2001; 357 GJ Wu (734_CR12) 2005; 1042 PJ Hanley (734_CR9) 2002; 544 M Doi (734_CR18) 2020; 34 Y Yoshikawa (734_CR20) 2024; 51 J Niezgoda (734_CR5) 2013; 23 M Colleoni (734_CR17) 1996; 78 A Kitaura (734_CR6) 2022; 8 OM Russell (734_CR1) 2020; 181 SW Nam (734_CR21) 2023; 70 PG Morgan (734_CR3) 2002; 96 G Hasegawa (734_CR22) 2022; 36 T Satoh (734_CR24) 2021; 2021 N Hirata (734_CR10) 2011; 115 AV Vanlander (734_CR16) 2012; 56 J Drissen (734_CR8) 2007; 17 S Hemphill (734_CR13) 2019; 122 |
| References_xml | – volume: 115 start-page: 531 year: 2011 end-page: 540 ident: CR10 article-title: Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning publication-title: Anesthesiology doi: 10.1097/ALN.0b013e31822a2316 contributor: fullname: Weihrauch – volume: 78 start-page: 69 year: 1996 end-page: 76 ident: CR17 article-title: Biochemical characterization of the effects of the benzodiazepine, midazolam, on mitochondrial electron transfer publication-title: Pharmacol Toxicol doi: 10.1111/j.1600-0773.1996.tb00182.x contributor: fullname: Santagostino – volume: 48 start-page: 413 year: 2016 end-page: 423 ident: CR11 article-title: Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity publication-title: J Bioenerg Biomembr doi: 10.1007/s10863-016-9673-9 contributor: fullname: Fato – volume: 7 start-page: 87 year: 2021 ident: CR26 article-title: Temporary worsening of mitral regurgitation due to conduction disturbance after transcatheter aortic valve implantation publication-title: JA Clin Rep doi: 10.1186/s40981-021-00491-3 contributor: fullname: Sawamura – volume: 1042 start-page: 168 year: 2005 end-page: 176 ident: CR12 article-title: Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1338.019 contributor: fullname: Chen – volume: 4 start-page: 70 year: 2018 ident: CR25 article-title: Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anesthesia: a retrospective study publication-title: JA Clin Rep doi: 10.1186/s40981-018-0207-9 contributor: fullname: Sugimoto – volume: 122 start-page: 448 year: 2019 end-page: 459 ident: CR13 article-title: Propofol infusion syndrome: a structured literature review and analysis of published case reports publication-title: Br J Anaesth doi: 10.1016/j.bja.2018.12.025 contributor: fullname: Hopkins – volume: 51 start-page: e13840 year: 2024 ident: CR20 article-title: Comparison of the negative effect of remimazolam and propofol on cardiac contractility: Analysis of a randomized parallel-group trial and a preclinical ex vivo study publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.13840 contributor: fullname: Edanaga – volume: 8 start-page: 38 year: 2022 ident: CR6 article-title: Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report publication-title: JA Clin Rep doi: 10.1186/s40981-022-00528-1 contributor: fullname: Nakao – volume: 357 start-page: 606 year: 2001 end-page: 607 ident: CR4 article-title: Impaired fatty acid oxidation in propofol infusion syndrome publication-title: Lancet doi: 10.1016/S0140-6736(00)04064-2 contributor: fullname: Shield – volume: 23 start-page: 785 year: 2013 end-page: 793 ident: CR5 article-title: Anesthetic considerations in patients with mitochondrial defect publication-title: Paediatr Anaesth doi: 10.1111/pan.12158 contributor: fullname: Morgan – volume: 2021 start-page: 5536442 year: 2021 ident: CR24 article-title: Remimazolam anesthesia for mitraclip implantation in a patient with advanced heart failure publication-title: Case Rep Anesthesiol contributor: fullname: Yamakage – volume: 37 start-page: 825 year: 2023 end-page: 827 ident: CR23 article-title: Remimazolam for cardiovascular anesthesia publication-title: J Anesth doi: 10.1007/s00540-023-03242-z contributor: fullname: Hirata – volume: 56 start-page: 520 year: 2012 end-page: 525 ident: CR16 article-title: Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome publication-title: Acta Anaesthesiol Scand doi: 10.1111/j.1399-6576.2011.02628.x contributor: fullname: Van den Eynden – volume: 44 start-page: 2361 year: 2023 end-page: 2362 ident: CR2 article-title: Mitochondrial cardiomyopathy: a fertile field for research publication-title: Eur Heart J doi: 10.1093/eurheartj/ehad177 contributor: fullname: Braunwald – volume: 544 start-page: 687 year: 2002 end-page: 693 ident: CR9 article-title: Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria publication-title: J Physiol doi: 10.1113/jphysiol.2002.025015 contributor: fullname: Daut – volume: 36 start-page: 239 year: 2022 end-page: 245 ident: CR22 article-title: Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction publication-title: J Anesth doi: 10.1007/s00540-022-03037-8 contributor: fullname: Yamakage – volume: 96 start-page: 1268 year: 2002 end-page: 1270 ident: CR3 article-title: Mitochondrial defects and anesthetic sensitivity publication-title: Anesthesiology doi: 10.1097/00000542-200205000-00036 contributor: fullname: Sedensky – volume: 181 start-page: 168 year: 2020 end-page: 188 ident: CR1 article-title: Mitochondrial diseases: hope for the future publication-title: Cell doi: 10.1016/j.cell.2020.02.051 contributor: fullname: Turnbull – volume: 34 start-page: 491 year: 2020 end-page: 501 ident: CR19 article-title: Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial publication-title: J Anesth. doi: 10.1007/s00540-020-02776-w contributor: fullname: Sakamoto – volume: 7 start-page: ytad440 year: 2023 ident: CR7 article-title: Successful transcatheter mitral valve repair for functional mitral regurgitation in a patient with mitochondrial cardiomyopathy: a case report publication-title: Eur Heart J Case Rep. doi: 10.1093/ehjcr/ytad440 contributor: fullname: Isobe – volume: 103 start-page: 909 year: 2005 ident: CR14 article-title: Acquired carnitine deficiency: a clinical model for propofol infusion syndrome? publication-title: Anesthesiology doi: 10.1097/00000542-200510000-00046 contributor: fullname: Ozaki – volume: 17 start-page: 16 year: 2007 end-page: 21 ident: CR8 article-title: Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects publication-title: Paediatr Anaesth doi: 10.1111/j.1460-9592.2006.02043.x contributor: fullname: Smeitink – volume: 34 start-page: 543 year: 2020 end-page: 553 ident: CR18 article-title: Efficacy and safety of remimazolam versus propofol for general anesthesia: multicenter, single-blind, randomized, parallel-group, phase IIb/III trial publication-title: J Anesth. doi: 10.1007/s00540-020-02788-6 contributor: fullname: Suzuki – volume: 70 start-page: 1495 year: 2023 end-page: 1503 ident: CR21 article-title: Effects of remimazolam on hemodynamic changes during cardiac ablation for atrial fibrillation under general anesthesia: a propensity-score-matched retrospective cohort study publication-title: Can J Anaesth doi: 10.1007/s12630-023-02514-2 contributor: fullname: Song – volume: 81 start-page: 770 year: 2013 end-page: 771 ident: CR15 article-title: Propofol-related infusion syndrome heralding a mitochondrial disease: case report publication-title: Neurology doi: 10.1212/WNL.0b013e3182a1aa78 contributor: fullname: Brunet – volume: 70 start-page: 1495 year: 2023 ident: 734_CR21 publication-title: Can J Anaesth doi: 10.1007/s12630-023-02514-2 contributor: fullname: SW Nam – volume: 36 start-page: 239 year: 2022 ident: 734_CR22 publication-title: J Anesth doi: 10.1007/s00540-022-03037-8 contributor: fullname: G Hasegawa – volume: 34 start-page: 543 year: 2020 ident: 734_CR18 publication-title: J Anesth. doi: 10.1007/s00540-020-02788-6 contributor: fullname: M Doi – volume: 122 start-page: 448 year: 2019 ident: 734_CR13 publication-title: Br J Anaesth doi: 10.1016/j.bja.2018.12.025 contributor: fullname: S Hemphill – volume: 44 start-page: 2361 year: 2023 ident: 734_CR2 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehad177 contributor: fullname: E Braunwald – volume: 115 start-page: 531 year: 2011 ident: 734_CR10 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e31822a2316 contributor: fullname: N Hirata – volume: 56 start-page: 520 year: 2012 ident: 734_CR16 publication-title: Acta Anaesthesiol Scand doi: 10.1111/j.1399-6576.2011.02628.x contributor: fullname: AV Vanlander – volume: 37 start-page: 825 year: 2023 ident: 734_CR23 publication-title: J Anesth doi: 10.1007/s00540-023-03242-z contributor: fullname: N Hirata – volume: 78 start-page: 69 year: 1996 ident: 734_CR17 publication-title: Pharmacol Toxicol doi: 10.1111/j.1600-0773.1996.tb00182.x contributor: fullname: M Colleoni – volume: 17 start-page: 16 year: 2007 ident: 734_CR8 publication-title: Paediatr Anaesth doi: 10.1111/j.1460-9592.2006.02043.x contributor: fullname: J Drissen – volume: 7 start-page: ytad440 year: 2023 ident: 734_CR7 publication-title: Eur Heart J Case Rep. doi: 10.1093/ehjcr/ytad440 contributor: fullname: T Huruma – volume: 2021 start-page: 5536442 year: 2021 ident: 734_CR24 publication-title: Case Rep Anesthesiol contributor: fullname: T Satoh – volume: 7 start-page: 87 year: 2021 ident: 734_CR26 publication-title: JA Clin Rep doi: 10.1186/s40981-021-00491-3 contributor: fullname: T Sajima – volume: 23 start-page: 785 year: 2013 ident: 734_CR5 publication-title: Paediatr Anaesth doi: 10.1111/pan.12158 contributor: fullname: J Niezgoda – volume: 51 start-page: e13840 year: 2024 ident: 734_CR20 publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.13840 contributor: fullname: Y Yoshikawa – volume: 48 start-page: 413 year: 2016 ident: 734_CR11 publication-title: J Bioenerg Biomembr doi: 10.1007/s10863-016-9673-9 contributor: fullname: C Bergamini – volume: 357 start-page: 606 year: 2001 ident: 734_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(00)04064-2 contributor: fullname: A Wolf – volume: 181 start-page: 168 year: 2020 ident: 734_CR1 publication-title: Cell doi: 10.1016/j.cell.2020.02.051 contributor: fullname: OM Russell – volume: 8 start-page: 38 year: 2022 ident: 734_CR6 publication-title: JA Clin Rep doi: 10.1186/s40981-022-00528-1 contributor: fullname: A Kitaura – volume: 544 start-page: 687 year: 2002 ident: 734_CR9 publication-title: J Physiol doi: 10.1113/jphysiol.2002.025015 contributor: fullname: PJ Hanley – volume: 4 start-page: 70 year: 2018 ident: 734_CR25 publication-title: JA Clin Rep doi: 10.1186/s40981-018-0207-9 contributor: fullname: E Fujii – volume: 1042 start-page: 168 year: 2005 ident: 734_CR12 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1338.019 contributor: fullname: GJ Wu – volume: 103 start-page: 909 year: 2005 ident: 734_CR14 publication-title: Anesthesiology doi: 10.1097/00000542-200510000-00046 contributor: fullname: S Uezono – volume: 34 start-page: 491 year: 2020 ident: 734_CR19 publication-title: J Anesth. doi: 10.1007/s00540-020-02776-w contributor: fullname: M Doi – volume: 81 start-page: 770 year: 2013 ident: 734_CR15 publication-title: Neurology doi: 10.1212/WNL.0b013e3182a1aa78 contributor: fullname: M Savard – volume: 96 start-page: 1268 year: 2002 ident: 734_CR3 publication-title: Anesthesiology doi: 10.1097/00000542-200205000-00036 contributor: fullname: PG Morgan |
| SSID | ssj0001626688 |
| Score | 2.3154461 |
| Snippet | Background
Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such... Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such cases is... BackgroundMitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in such... Abstract Background Mitochondrial cardiomyopathy occurs when impaired mitochondrial energy production leads to myocardial dysfunction. Anesthetic management in... |
| SourceID | doaj proquest crossref pubmed springer |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | 49 |
| SubjectTerms | Anesthesia Anesthesiology Cardiac function Cardiomyopathy Case Report Critical Care Medicine Emergency Medicine Intensive Medicine Medicine & Public Health Mitochondrial cardiomyopathy MitraClip Pain Medicine Patients Percutaneous mitral valve repair Remimazolam |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LTtwwFLWAVTcI1AdpaXUrdddGJHHGdrqjFMSqmxaJneWnNBKTQTMMFfwFf9x77UwAQdVNt4ljJT4n9-FrHzP2ScXa2qYOJRfBYYLSqtJ6x8t2EoVoAmlc0tTA6U_541x9PyaZnPGoL1oTluWB88AdmNoZ55y3Vpk2cmmjVUoYtLwN963POp-VeJBMpdkVjNOFUutdMkocLDGRUZg5N21J1am2vH3kiZJg_3NR5pMKaXI8Jztse4gY4TC_6S7bCP1LdneIJgpjt-XUwGxcwQIYgcJlWLgVhnwBc3qYTWkmA5BO1wEW6HqmC5j2YGDQUwWah6VWczSDvSc2gktLVGc3czqt-AZM7-Fi_jtfNg7IExKaX7EXhz4QctnhFTs7Of51dFoOpyuUruX8Ci1LXXfR4qAgWi1tqXWG6mxcus7WFvMwF6qmM1U0cSKd55LXMUovTAzoWAV_zbb6eR_2GCgbEGWJaCiJCVdjwsRwfFQhah2CUbDP65HWl1lEQ6fkQwmdcdGIi0646NuCfSMwxpYkgJ0uIC30QAv9L1oUbH8NpR7-yqXmVYcREqZsqmAfx9v4P1GRJOOS2giOVgu7eJMpML4J70iaqJIF-7LmxH3nf_-gt__jg96xF00iLwmK77Otq8UqvGebS7_6kKj_B0GICoQ priority: 102 providerName: Directory of Open Access Journals |
| Title | Anesthesia management for percutaneous mitral valve repair in a patient with mitochondrial cardiomyopathy and low cardiac function: a case report |
| URI | https://link.springer.com/article/10.1186/s40981-024-00734-z https://www.ncbi.nlm.nih.gov/pubmed/39115707 https://www.proquest.com/docview/3090756068 https://www.proquest.com/docview/3090637933 https://doaj.org/article/a1cacccdbb8a4f37bfb886a30323d4d3 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIiEuvB-BsjISNwhsYq_tcCulVS9wASRulu3YaFU2qZIuqP0X_GNmnAdClANcHdtxPN-84zHAMx0L58oi5FwGjw6K0LmrPc_FKkpZBqpxSaGB4w_q_Wf99pDK5PA5dNGcvJwykklQJ67W8lWPjohGz7cUOWWXRH6xA1fReBB0bcHBeMQhBVbQRJdaTwdkLh36mxJKtfovMzD_SI4mnXN0879WewtujCYm2x8wcRuuhOYOXHs3JtHvwo99FG9o9_Vryzbz3y8MrVd2Gjq_RXMxtNuebdYUBWEIxW-Bdai21h1bN8yysRYroxgu9WpRhDY1IZn59Hvr5rylm47PmW1q9rX9PjRbz0iLEhJe4ywe9ScbUhb34NPR4ceD43y8mSH3gvMzlEpFUUWHn4iUFnQc11vK0XHlK1c49OF8WJaVXUYbV8rXXPEiRlVLGwMqZcnvw27TNuEhMO0CIkSJmmuFzlppw8pyHKpr5yqkZgbPJ1KZ06EAh0mOi5Zm2GWDu2zSLpuLDN4QNeeeVDw7NbTdFzPyorGFt957fIG2InLlotNaWlTmJa9xIRnsTVgwI0f3hi8rtK7Q3dMZPJ0fIy9SgmWgS-ojOUo8nOLBgKF5JbyiskZLlcGLCTG_Jv_7Bz36t-6P4XqZQEdlx_dg96zbhiew09fbReKSRYo5LFJQ6yfUNxFh |
| link.rule.ids | 315,782,786,866,2106,27933,27934,41128,42197,52242 |
| linkProvider | Springer Nature |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIkEv5U1TChiJG0TdxF7H4VZKq0W0vVAkbpbt2GglNqmSLqj9F_3HnXGSRYhygKtjO7bnm5fHHgO8ViGzNs98yqV36KAIldrK8VRMg5S5pxyXtDUw-1ycfFUfDihNjhjvwsTT7mNIMkrqyNZK7nboiSh0fXORUnhJpJdrcFsgw5HLtT_ccYg7K2ijS6XGGzI3Nv1NC8Vk_TdZmH9ER6PSObz3f8O9D5uDkcn2elQ8gFu-fgh3jocw-iO42kMBh5ZfNzdssTr_wtB-ZWe-dUs0GH2z7NhiTvsgDMH4w7MWFde8ZfOaGTZkY2W0i0u1GhSidUVYZi4ecF1cNPTW8QUzdcW-Nz_7YuMY6VHCwjvsxaEGZX3Q4jF8OTw43Z-lw9sMqROcn6NcyrIyWJwi0lrQhVxnKErHC1fazKIX5_wkL80kmDAtXMULnoVQVNIEj2pZ8iewXje13wKmrEeMFKLiqkB3LTd-ajg2VZW1JZIzgTcjrfRZn4JDR9dFSd2vssZV1nGV9WUC74mcq5qUPjsWNO03PXCjNpkzzjn8gTIi8MIGq5Q0qM5zXuFAEtgZwaAHnu40n5RoX6HDpxJ4tfqM3Eghlp4usY7kKPOwi6c9iFYj4SUlNpoUCbwdEfOr879PaPvfqr-Eu7PT4yN99PHk0zPYyCMAKQn5Dqyft0v_HNa6avkissw1GxwTNg |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RIlVceD8CBYzEDaJu4qzjcCttV0VAhQRI3Cw_q5XYZLXZbdX-C_4xM84DIcoBcXUcx7G_8cx4PJ8BXsqQGZNnPuXCW3RQCpkaZ3laTIMQuSeOS9oaOP5cnnyTh0dEkzNm8cfT7kNIsstpIJamer23dKETcSn2WvRKJLrBeZFSqKlIL7fgeoGmAx3qOujzHeIuC9rrQsohW-bKV3_TSJG4_ypr849IaVRAs1v_3_XbcLM3Ptl-h5Y7cM3Xd2HnYx9evwc_9nHhQ4uwnWu2GM_FMLRr2dKv7AYNSd9sWraY0_4IQ5CeebZChTZfsXnNNOtZWhnt7lKtBhfX2hHGmY0HXxcXDd2BfMF07dj35rwr1paRfiWMvMFWLGpW1gUz7sPX2dGXg-O0v7MhtQXna1yvsqwKBn8RMVBQoq7VFL3jpa1MZtC7s36SV3oSdJiW1vGSZyGUTujgUV0L_gC266b2j4BJ4xE7ZeG4LNGNy7Wfao6vSmdMhVObwKth3tSyo-ZQ0aWRQnWjrHCUVRxldZnAW5rasSbRaseCZnWqeilVOrPaWosfkLoIvDTBSCk0qvmcO-xIArsDMFQv663ikwrtLnQEZQIvxscopRR66eYl1hEc10Js4mEHqLEnvCLCo0mZwOsBPb8a__sPPf636s9h59PhTH14d_L-CdzII_6Im3wXtterjX8KW63bPIvS8xNBDRwR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anesthesia+management+for+percutaneous+mitral+valve+repair+in+a+patient+with+mitochondrial+cardiomyopathy+and+low+cardiac+function%3A+a+case+report&rft.jtitle=JA+clinical+reports&rft.au=Tashima%2C+Koichiro&rft.au=Hayashi%2C+Masakiyo&rft.au=Oyoshi%2C+Takafumi&rft.au=Uemura%2C+Jo&rft.date=2024-08-08&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=2363-9024&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1186%2Fs40981-024-00734-z&rft.externalDocID=10_1186_s40981_024_00734_z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2363-9024&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2363-9024&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2363-9024&client=summon |